These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. No major role for atrial natriuretic peptide in the vasodilator response to endothelin-1 in the spontaneously hypertensive rat. Fozard JR; Part ML Eur J Pharmacol; 1990 May; 180(1):153-9. PubMed ID: 2142091 [TBL] [Abstract][Full Text] [Related]
63. Defective cyclic GMP accumulation in spontaneously hypertensive rat aorta in response to atrial natriuretic factor. Sauro MD; Fitzpatrick DF; Coffey RG Biochem Pharmacol; 1988 Jun; 37(11):2109-12. PubMed ID: 2837225 [No Abstract] [Full Text] [Related]
65. Atrial natriuretic peptide interferes with calcium requirements in vascular tissues of the rat. St-Louis J; Coderre C; Schiffrin EL Can J Physiol Pharmacol; 1988 Jul; 66(7):963-6. PubMed ID: 2975193 [TBL] [Abstract][Full Text] [Related]
66. Modulation of vascular tone by atrial natriuretic factor. Winquist RJ Blood Vessels; 1987; 24(3):128-31. PubMed ID: 3036282 [TBL] [Abstract][Full Text] [Related]
67. Interactions between endothelin and atrial natriuretic factor in the rat aortic ring preparation. Bolger G; Liard F; Krogsrud R; Welchner E; Jaramillo J Can J Physiol Pharmacol; 1991 Aug; 69(8):1155-62. PubMed ID: 1838297 [TBL] [Abstract][Full Text] [Related]
68. Barbiturate tolerance and hypersensitivity of arterial smooth muscle. Altura BM; Altura BT Drug Alcohol Depend; 1979 Nov; 4(6):467-73. PubMed ID: 533681 [TBL] [Abstract][Full Text] [Related]
69. Resolution of experimental microvascular vasoconstriction in rats by topical application of lidocaine hydrochloride in varying concentrations. Beekman WH; Sluimers JE; Kort WJ; van der Meulen JC Ann Plast Surg; 1988 Dec; 21(6):570-5. PubMed ID: 3239936 [TBL] [Abstract][Full Text] [Related]
70. Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor regulation. Larose L; Rondeau JJ; Ong H; De Léan A Mol Cell Biochem; 1992 Oct; 115(2):203-11. PubMed ID: 1280321 [TBL] [Abstract][Full Text] [Related]
71. Possible mechanisms underlying the vasorelaxant response to atrial natriuretic factor. Winquist RJ Fed Proc; 1986 Aug; 45(9):2371-5. PubMed ID: 3015691 [TBL] [Abstract][Full Text] [Related]
72. Decreased sensitivity of spontaneously hypertensive rat aortic smooth muscle to vasorelaxation by atriopeptin III. Sauro MD; Fitzpatrick DF Biochem Biophys Res Commun; 1987 Jul; 146(1):80-6. PubMed ID: 2955788 [TBL] [Abstract][Full Text] [Related]
73. Long-term inhibition of angiotensin converting enzyme suppresses calcium channel agonist-induced contraction of aorta in hypertensive rats. Sada T; Koike H; Miyamoto M Hypertension; 1989 Dec; 14(6):652-9. PubMed ID: 2583800 [TBL] [Abstract][Full Text] [Related]
75. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid. Ajay M; Achike FI; Mustafa MR Pharmacol Res; 2007 May; 55(5):385-91. PubMed ID: 17317209 [TBL] [Abstract][Full Text] [Related]
76. Atrial peptides inhibit protein kinase C-mediated contraction in rat aorta. Sauro MD; Fitzpatrick DF Eur J Pharmacol; 1990 May; 180(2-3):373-6. PubMed ID: 2142097 [TBL] [Abstract][Full Text] [Related]